THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment: a multi-centre, assessor blind, randomised controlled trial – THRIVE trial

Matthew Machin, Sarah Whittley, John Norrie, Laura Burgess, Beverley J Hunt, Layla Bolton-Saghdaoui, Joseph Shalhoub, Tamara Everington, Manjit Gohel, Mark Whiteley, Steven Rogers, Sarah Onida, Benedict Turner, Sandip Nandhra, Rebecca Lawton, Annya Stephens-Boal, Carolyn Singer, Joanne Dunbar, Daniel Carradice, Alun Huw Davies
doi: https://doi.org/10.1101/2023.12.19.23300215

Article Information

doi 
https://doi.org/10.1101/2023.12.19.23300215
History 
  • December 19, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Matthew Machin1,2,
  2. Sarah Whittley1,
  3. John Norrie3,
  4. Laura Burgess1,
  5. Beverley J Hunt4,
  6. Layla Bolton-Saghdaoui2,
  7. Joseph Shalhoub1,2,
  8. Tamara Everington5,
  9. Manjit Gohel6,
  10. Mark Whiteley7,
  11. Steven Rogers8,9,
  12. Sarah Onida1,2,
  13. Benedict Turner1,
  14. Sandip Nandhra10,
  15. Rebecca Lawton1,
  16. Annya Stephens-Boal1,
  17. Carolyn Singer1,
  18. Joanne Dunbar1,
  19. Daniel Carradice11 and
  20. Alun Huw Davies1,2,*
  1. 1Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London W6 8RF, United Kingdom
  2. 2Imperial Vascular Unit, Imperial College Healthcare NHS Trust, St Mary’s Hospital, London W2 1NY, United Kingdom
  3. 3Usher Institute of Population Health Sciences and Informatics, Edinburgh Clinical Trials Unit, University of Edinburgh, Level 2, NINE Edinburgh BioQuarter, 9 Little France Road, Edinburgh, EH16 4UX, United Kingdom
  4. 4Thrombosis & Haemophilia Centre, Guy’s and St Thomas’ NHS Foundation Trust, Westminster Bridge Road, London, SE1 7EH, United Kingdom
  5. 5Hampshire Hospitals NHS Foundation Trust, Aldermaston Road, Basingstoke, Hampshire, RG24 9NA, United Kingdom
  6. 6Cambridge Vascular Unit, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, CB2 0QQ, United Kingdom
  7. 7The Whiteley Clinic, 1 Chapel Place, London, W1G 0BG, United Kingdom
  8. 8Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PL, United Kingdom
  9. 9Manchester Academic Vascular Research and Innovation Centre (MAVRIC), Manchester University NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, United Kingdom
  10. 10Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, NEW1 7RU, United Kingdom
  11. 11Academic Vascular Surgical Unit, Hull York Medical School, Allam Diabetes Centre, Hull Royal Infirmary, Anlaby Road, Hull, HU3 2JZ, United Kingdom
  1. ↵*Corresponding author:
    Professor Alun H. Davies, Professor of Vascular Surgery, Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, Charing Cross Hospital, London W6 8RF, United Kingdom. Email: a.h.davies{at}imperial.ac.uk.
Back to top
Posted December 19, 2023.
Download PDF
Data/Code
Email
THRomboprophylaxis in Individuals undergoing superficial endoVEnous treatment: a multi-centre, assessor blind, randomised controlled trial – THRIVE trial
Matthew Machin, Sarah Whittley, John Norrie, Laura Burgess, Beverley J Hunt, Layla Bolton-Saghdaoui, Joseph Shalhoub, Tamara Everington, Manjit Gohel, Mark Whiteley, Steven Rogers, Sarah Onida, Benedict Turner, Sandip Nandhra, Rebecca Lawton, Annya Stephens-Boal, Carolyn Singer, Joanne Dunbar, Daniel Carradice, Alun Huw Davies
medRxiv 2023.12.19.23300215; doi: https://doi.org/10.1101/2023.12.19.23300215
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area